Nicorette Lozenge Product

DRUG3 trials

Sponsors

Ottawa Heart Institute Research Corporation, Rose Research Center, LLC

Conditions

Coronary Artery DiseaseHarm ReductionSmoking Cessation

Phase 3

Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT

TerminatedNCT06088862

Rose Research Center, LLCHarm Reduction, Smoking Cessation

Start: 2023-12-27End: 2024-04-30Updated: 2025-03-30

Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders

CompletedNCT06554873

Rose Research Center, LLCHarm Reduction, Smoking Cessation

Start: 2024-08-29End: 2025-12-09Updated: 2026-02-06

Unknown Phase

Cytisine Compared to Combination NRT in Relapsed Smokers

TerminatedNCT04286295

Ottawa Heart Institute Research CorporationCoronary Artery Disease, Smoking Cessation

Start: 2022-03-14End: 2023-11-07Updated: 2023-12-08

Related Papers

Cytisine Use Vs Nicotine Replacement Therapy in Relapsed Smokers with Heart Disease: Feasibility Results from a Pilot Randomized Trial.

2025-05-16

Cytisine compared to combination nicotine replacement therapy to reduce cigarette consumption in relapsed smokers: protocol for a pilot randomized controlled trial

Pilot and Feasibility Studies2025-01-282 citations